CellectGen Advances Periodontal Diagnostics in Collaboration with Kemp Proteins and DCNDx
Pasadena, CA,— CellectGen has received Small Business Innovation Research (SBIR) funding to develop a saliva-based, point-of-care diagnostic platform for periodontal disease, focused on early detection of active tissue destruction. About 42% of U.S. adults over 30 have periodontal disease, a leading cause of adult tooth loss that contributes to an estimated $154 billion in direct […]